Hypophosphatemia as an Early Metabolic Bone Disease Marker in Extremely Low-Birth-Weight Infants After Prolonged Parenteral Nutrition Exposure

Tan Y.-L.PO-NIEN TSAOHUNG-CHIEH CHOUTING-AN YENCHIEN-YI CHEN2021-01-212021-01-212021-080148-6071https://www.scopus.com/inward/record.uri?eid=2-s2.0-85091306250&doi=10.1002%2fjpen.2010&partnerID=40&md5=f30370379d3f7fcaa5c5c7e2984252dahttps://scholars.lib.ntu.edu.tw/handle/123456789/541600Background: Early metabolic bone disease (MBD) detection is important in preterm infants to decrease long-term consequence. We aim to explore the early MBD biochemical marker in extremely low-birth-weight (ELBW) infants. Methods: Retrospective cohort studen[SDGs]SDG3alkaline phosphatase; amino acid; biochemical marker; calcium; glucose; lipid emulsion; loop diuretic agent; parenteral solution; phosphorus; smoflipid; steroid; biological marker; alkaline phosphatase level; Article; birth weight; calcium blood level; coHypophosphatemia as an Early Metabolic Bone Disease Marker in Extremely Low-Birth-Weight Infants After Prolonged Parenteral Nutrition Exposurejournal article10.1002/jpen.2010328604292-s2.0-85091306250